FDA Approves Klisyri
FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp BUFFALO, N.Y., Dec. 15, 2020 […]
November 25, 2020 — Under FDA law, approval of a new drug requires substantial evidence of effectiveness and a demonstration […] Fox News Flash top headlines for October 15 Fox News Flash top headlines are here. Check out what’s clicking on […] (HealthDay)—Reacting to an upsurge in abuse of benzodiazepine sedatives such as Valium, Xanax and Ativan, U.S. officials on Wednesday added […] WEDNESDAY, Sept. 23, 2020 — Stricter guidelines for emergency authorization use of a vaccine against the new coronavirus could soon […] FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — […] (HealthDay)—A new drug to treat most cystic fibrosis patients has been approved by the U.S. Food and Drug Administration. Trikafta […] This week, the FDA warned pet owners about the dangers of xylitol, a type of sugar alcohol that is sometimes […] (HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. […] HOUSTON, TX / ACCESSWIRE / March 13, 2019 / Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical […]FDA
FDA: Remdesivir (Veklury) Approval for the Treatment of COVID-19 – The Evidence for Safety and Efficacy
Regeneron's Ebola drug gets first-ever FDA approval
FDA adds abuse warning to labels for Xanax, Valium
Stricter Vaccine Approval Rules Coming From FDA
FDA Approves Qdolo
FDA approves new drug for most common form of cystic fibrosis
This common sugar substitute can be deadly for dogs, FDA warns
FDA approves venetoclax for chronic, small lymphocytic leukemia
Moleculin Files with FDA for Expedited Approval Pathway for Annamycin